Allinaire Therapeutic ( Worldwide Rights To a Portfolio of Therapeutic Monoclonal Antibodies) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Allinaire Therapeutic ( Worldwide Rights To a Portfolio of Therapeutic Monoclonal Antibodies) General Information

Description

The worldwide rights to a portfolio of therapeutic monoclonal antibodies intended to provide potential treatment of PAH.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 2000 Auburn Drive
  • Suite 200
  • Beachwood, OH 44122
  • United States
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Corporate Office
  • 2000 Auburn Drive
  • Suite 200
  • Beachwood, OH 44122
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Allinaire Therapeutic ( Worldwide Rights To a Portfolio of Therapeutic Monoclonal Antibodies) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Allinaire Therapeutic ( Worldwide Rights To a Portfolio of Therapeutic Monoclonal Antibodies)‘s full profile, request access.

Request a free trial

Allinaire Therapeutic ( Worldwide Rights To a Portfolio of Therapeutic Monoclonal Antibodies) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Allinaire Therapeutic ( Worldwide Rights To a Portfolio of Therapeutic Monoclonal Antibodies)‘s full profile, request access.

Request a free trial

Allinaire Therapeutic ( Worldwide Rights To a Portfolio of Therapeutic Monoclonal Antibodies) FAQs

  • Where is Allinaire Therapeutic ( Worldwide Rights To a Portfolio of Therapeutic Monoclonal Antibodies) headquartered?

    Allinaire Therapeutic ( Worldwide Rights To a Portfolio of Therapeutic Monoclonal Antibodies) is headquartered in Beachwood, OH.

  • What industry is Allinaire Therapeutic ( Worldwide Rights To a Portfolio of Therapeutic Monoclonal Antibodies) in?

    Allinaire Therapeutic ( Worldwide Rights To a Portfolio of Therapeutic Monoclonal Antibodies)’s primary industry is Drug Discovery.

  • Is Allinaire Therapeutic ( Worldwide Rights To a Portfolio of Therapeutic Monoclonal Antibodies) a private or public company?

    Allinaire Therapeutic ( Worldwide Rights To a Portfolio of Therapeutic Monoclonal Antibodies) is a Private company.

  • What is Allinaire Therapeutic ( Worldwide Rights To a Portfolio of Therapeutic Monoclonal Antibodies)’s current revenue?

    The current revenue for Allinaire Therapeutic ( Worldwide Rights To a Portfolio of Therapeutic Monoclonal Antibodies) is .

  • Who are Allinaire Therapeutic ( Worldwide Rights To a Portfolio of Therapeutic Monoclonal Antibodies)’s investors?

    Allinaire Therapeutics has invested in Allinaire Therapeutic ( Worldwide Rights To a Portfolio of Therapeutic Monoclonal Antibodies).

  • When was Allinaire Therapeutic ( Worldwide Rights To a Portfolio of Therapeutic Monoclonal Antibodies) acquired?

    Allinaire Therapeutic ( Worldwide Rights To a Portfolio of Therapeutic Monoclonal Antibodies) was acquired on 02-May-2022.

  • Who acquired Allinaire Therapeutic ( Worldwide Rights To a Portfolio of Therapeutic Monoclonal Antibodies)?

    Allinaire Therapeutic ( Worldwide Rights To a Portfolio of Therapeutic Monoclonal Antibodies) was acquired by Chiesi Farmaceutici.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process